Exchange: NASDAQ·Updated 07:30 PM EST

SNY Earnings

Latest Earnings Results: Q3 '26

Reported: Oct 30

Estimated EPS

$1.55

Reported EPS

$1.98

Surprise

+27.46%

Estimated Rev

$15.18B

Reported Rev

$15.87B

Surprise

+4.55%

• Reported GAAP EPS of $2.01 up 17.54% YoY • Reported revenue of $17.25B up 11.64% YoY • Sanofi upgraded FY 2026 guidance: sales are expected to grow by a low-teens percentage at CER, and business EPS at CER is expected to grow by a mid-teens percentage.

Generated by Stocktwits using AI and company-reported earnings data for Q3 '26. This recap is intended to help readers understand the quarter quickly. Verify key figures in the linked source materials; the summary may contain errors and is not investment advice.

Investor Presentation6-K

Historical Earnings

Quarterly

Annual

EPS

Revenue

Fiscal PeriodEstimatedReportedSurpriseResult
Q4 '26
$0.91
--
--
N/A
Q3 '26
$1.55
$1.98
27.46%
BEAT
Q2 '26
$1.07
$1.20
11.83%
BEAT
Q1 '26
$1.04
$1.10
6.21%
BEAT
Q4 '25
$0.84
$0.91
8.38%
BEAT

Advertisement|Remove ads.